1
2
Seferina, S.C., Lobbezoo, D.J.A., de Boer, M., Dercksen, M.W., van den Berkmortel, F., van Kampen, R.J.W., van de Wouw, A.J., de Vries, B., Joore, M.A., Peer, P.G.M., Voogd, A.C., Tjan-Heijnen, V.C.G.
Veröffentlicht in: Seferina , S C , Lobbezoo , D J A , de Boer , M , Dercksen , M W , van den Berkmortel , F , van Kampen , R J W , van de Wouw , A J , de Vries , B , Joore , M A , Peer , P G M , Voogd , A C & Tjan-Heijnen , V C G 2015 , ' Real-Life Use and Effectiveness of Adjuvant Trastuzumab in Early Breast Cancer Patients: A Study of the Southeast Netherlands Breast Cancer Consortium ' , Oncologist , vol. 20 , no. 8 , pp. 856-863 . https://doi.org/10.1634/theoncologist.2015-0006;
2015
Veröffentlicht in: Seferina , S C , Lobbezoo , D J A , de Boer , M , Dercksen , M W , van den Berkmortel , F , van Kampen , R J W , van de Wouw , A J , de Vries , B , Joore , M A , Peer , P G M , Voogd , A C & Tjan-Heijnen , V C G 2015 , ' Real-Life Use and Effectiveness of Adjuvant Trastuzumab in Early Breast Cancer Patients: A Study of the Southeast Netherlands Breast Cancer Consortium ' , Oncologist , vol. 20 , no. 8 , pp. 856-863 . https://doi.org/10.1634/theoncologist.2015-0006;
2015
3
Lobbezoo, D.J.A., van Kampen, R.J.W., Voogd, A. C., Dercksen, M. W., van den Berkmortel, F., Smilde, T. J., van de Wouw, A. J., Peters, F. P. J., van Riel, J. M. G. H., Peters, N. A. J. B., de Boer, M., Peer, P. G. M., Tjan-Heijnen, V. C. G.
Veröffentlicht in: Lobbezoo , D J A , van Kampen , R J W , Voogd , A C , Dercksen , M W , van den Berkmortel , F , Smilde , T J , van de Wouw , A J , Peters , F P J , van Riel , J M G H , Peters , N A J B , de Boer , M , Peer , P G M & Tjan-Heijnen , V C G 2016 , ' In real life, one-quarter of patients with hormone receptor-positive metastatic breast cancer receive chemotherapy as initial palliative therapy: a study of the Southeast Netherlands Breast Cancer Consortium ' , Annals of Oncology , vol. 27 , no. 2 , pp. 256-262 . https://doi.org/10.1093/annonc/mdv544;
2016
Veröffentlicht in: Lobbezoo , D J A , van Kampen , R J W , Voogd , A C , Dercksen , M W , van den Berkmortel , F , Smilde , T J , van de Wouw , A J , Peters , F P J , van Riel , J M G H , Peters , N A J B , de Boer , M , Peer , P G M & Tjan-Heijnen , V C G 2016 , ' In real life, one-quarter of patients with hormone receptor-positive metastatic breast cancer receive chemotherapy as initial palliative therapy: a study of the Southeast Netherlands Breast Cancer Consortium ' , Annals of Oncology , vol. 27 , no. 2 , pp. 256-262 . https://doi.org/10.1093/annonc/mdv544;
2016